Stifel initiates coverage on CRNX, a clinical-stage pharmaceutical company focused on endocrine diseases and tumors.
Kaken Pharmaceutical will hand Alumis $40 million in the near term for the rights to develop a late-stage tyrosine kinase 2 ...
BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price target increased by equities researchers at JPMorgan Chase & ...
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shot up 8.9% during trading on Monday after JPMorgan Chase & Co. raised their price target on the stock from $44.00 to $50.00. JPMorgan ...
BuzzFeed on MSN1d
Why You Get Chin Hairs As You Get Older, According To DoctorsKausel noted that while a little chin hair here and there in older women is normal, it should be minimal. If you notice a lot ...
Approximately one in every 100 babies born in the United States has congenital heart disease, often requiring cardiac surgery ...
My message to everyone is simple—take the first step, seek professional advice, and remember, "The best investment you can ...
Primary care clinicians are often the most accessible to patients and play a crucial role in the early detection and ...
Abbreviations: ACTH = adrenocorticotropic hormone; AME = apparent mineralocorticoid excess; CAH = congenital adrenal hyperplasia; DOC = deoxycorticosterone; FH-I = familial hyperaldosteronism type ...
Majority of Participants Reached a Defined Threshold for Remission of Tardive Dyskinesia Regardless of Underlying Psychiatric Disorder <l ...
Leydig cell tumours (LCT) are rare sex-cord gonadal tumours that account for less than 5% of testicular neoplasms. They are ...
Department of Congenital Heart Disease ... after stage II reconstructive surgery for hypoplastic left heart syndrome (HLHS) and to determine whether coil occlusion prevents the need for surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback